Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Bio-Techne (TECH) Cash from Operations (2009 - 2026)

Bio-Techne (TECH) posted quarterly Cash from Operations of 86661000.0 for Q1 2026, up 110.75% year-over-year from 41120000.0 in Q1 2025, and up 5.16% quarter-over-quarter from 82411000.0 in Q4 2025.

Analysis

Bio-Techne (TECH) Cash from Operations (2009 - 2026) Analysis & Trends

Bio-Techne's Cash from Operations history runs 18 years deep, the most recent figure standing at 86661000.0 for Q1 2026.

  • In Q1 2026, Cash from Operations rose 110.75% year-over-year to 86661000.0; the TTM figure through Mar 2026 stood at 294858000.0 (up 11.33% YoY), while the FY2025 annual figure was 287556000.0, down 3.82% from the prior year.
  • Cash from Operations for Q1 2026 stood at 86661000.0, up from 82411000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 102717000.0 in Q2 2022, with the low at 27585000.0 in Q3 2025.
  • The 5-year median for Cash from Operations is 75496000.0 (2024), against an average of 71378352.94.
  • The sharpest annual moves came in 2025 and 2026: Cash from Operations plunged 56.82% in 2025, then jumped 110.75% in 2026.
  • Bio-Techne's Cash from Operations stood at 64384000.0 in 2022, then increased by 29.09% to 83116000.0 in 2023, then grew by 1.48% to 84346000.0 in 2024, then retreated by 2.29% to 82411000.0 in 2025, then rose by 5.16% to 86661000.0 in 2026.
  • Business Quant data shows TECH's Cash from Operations at 86661000.0 in Q1 2026, 82411000.0 in Q4 2025, and 27585000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -526.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -387.32 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 462.82 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 326.72 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 728.46 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -88.83 Mn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn 95.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 95.42 Mn
Mar 31, 2026 86.66 Mn
Dec 31, 2025 82.41 Mn
Sep 30, 2025 27.59 Mn
Jun 30, 2025 98.20 Mn
Mar 31, 2025 41.12 Mn
Dec 31, 2024 84.35 Mn
Sep 30, 2024 63.89 Mn
Jun 30, 2024 75.50 Mn
Mar 31, 2024 80.99 Mn
Dec 31, 2023 83.12 Mn
Sep 30, 2023 59.38 Mn
Jun 30, 2023 83.39 Mn
Mar 31, 2023 50.54 Mn
Dec 31, 2022 64.38 Mn
Sep 30, 2022 56.08 Mn
Jun 30, 2022 102.72 Mn
Mar 31, 2022 73.13 Mn
Dec 31, 2021 100.99 Mn
Sep 30, 2021 48.43 Mn